Nitrong, Trinipatch, Nitrosylon

Nitrong, Trinipatch, Nitrosylon

Products
Nitrong, Trinipatch, Nitrosylon
Nitrong, Trinipatch, Nitrosylon

Information

A latest generation nitroglycerin patch for the treatment of coronary artery disease and heart failure. Transdermal Drug Delivery Systems (TDDS) are one of the pharmaceutical technologies, in which Lavipharm is actively and successfully engaged. TDDSs are placed on the skin and allow specific drug substances to penetrate into the bloodstream through the layers of the skin. This controlled delivery has many benefits compared to other forms, but most importantly, it offers safety and a better quality of life to the patient.
Distribution Areas
North America (USA, Canada)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)
Supplied From
Greece
All categories
Finished Dosage FormsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)Transdermal PatchesContract ManufacturingProductsServices
Main Categories
Finished Dosage FormsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs)
Lavipharm SALavipharm is an integrated group engaged in the research, development, manufacturing, import, marketing and sales, distribution, and wholesaling of pharmaceutical and healthcare products in Greece, with a strong international activity. Since 1911, the Company has established a solid commercial position in Greece, while over the years it has evolved into a leading developer and manufacturer of drug delivery systems, mainly TTS, both locally and internationally.

Log in

See all the content and easy-to-use features by logging in or registering!